Get the Latest Investment Ideas Delivered Straight to Your Inbox.

News Update


Changes to Licensing of Cannabis Firm's Subsidiary Expands Legal Scope
News Update


New opportunities should be a win-win for both company and subsidiary.

Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB) announced in a news release that its subsidiary, Toronto Herbal Remedies (THR), received a new license under the Cannabis Act and its regulations. The license allows the company to, in part, sell cannabis to other licensed producers. The Health Canada license also allows THR to possess cannabis and to produce dried and fresh cannabis, cannabis plants or seeds by cultivation, propagation and harvest.

Additionally, as of Nov. 10, 2018, THR received license amendments approving all of the remaining 16,600 square feet at the facility for additional grow operations.

"This is yet another step towards our facility being fully operational in 2019," Sproutly President and CEO Keith Dolo said in the release. "This license provides THR the ability to expedite our operational model as well as provide THR with additional avenues for the sale of our products when ready."

Sproutly noted that it will keep executing its operational plan in Canada and in other regulated jurisdictions.


1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Sproutly Canada. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with Sproutly Canada. Please click here for more information.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Sproutly Canada, a company mentioned in this article.

Want to read more about Cannabis investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe